SIRT1 and neoplasm: Thus, we postulate that lactate produced by glycolytic tumor cells is exported across the cell membrane to the tumor microenvironment by MCTs and, according with tumor metabolic symbiosis theory, it might be used by adjacent tumor and normal cells through an NAD+-dependent pathway, leading to a decreased NAD+/NADH ratio, resulting in SIRT1 inhibition.